FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice

Carole Devaux, Quentin Etienne, Jacques H. M. Cohen, Xavier Dervillez

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Pages456-457
Publication statusPublished - Oct 2019
Event17th European Meeting on Complement in Human Disease (EMCHD) - Madrid, Spain
Duration: 14 Sep 201917 Sep 2019

Conference

Conference17th European Meeting on Complement in Human Disease (EMCHD)
Country/TerritorySpain
CityMadrid
Period14/09/1917/09/19

Cite this